Lexeo Therapeutics
Latest round
- Series B
Last raised
- Sep 2021
Total raised
- $185M
Investors
- 15
About Lexeo Therapeutics
Based in New York, US, and founded in 2018 by Ronald G. Crystal, Lexeo Therapeutics, Inc. is a biotechnology company that develops adeno-associated virus (AAV)-mediated therapies. In May 2025, Lexeo Therapeutics, Inc. The company trades on NASDAQ under the ticker symbol LXEO. Lexeo Therapeutics develops and provides AAV (adeno-associated virus)-mediated therapies to treat patients with genetic diseases. The company's pipeline includes three clinical-stage gene therapy programs in monogenic diseases and up to 15 potential additional AAV gene therapy programs in monogenic and acquired diseases. The company’s preclinical pipeline includes monogenic diseases as well as hereditary and acquired diseases.
Who invested in Lexeo Therapeutics
15 investors across 2 rounds
See all investors in Lexeo Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lexeo Therapeutics
Who invested in Lexeo Therapeutics?
Lexeo Therapeutics has 15 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lexeo Therapeutics raised?
Lexeo Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Lexeo Therapeutics last raise money?
Lexeo Therapeutics's most recent round on record is a Series B, in Sep 2021.
What does Lexeo Therapeutics do?
Based in New York, US, and founded in 2018 by Ronald G.
Where is Lexeo Therapeutics headquartered?
Lexeo Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Lexeo Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lexeo Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Lexeo Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.